Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...
Low Quantity of Opioids Used After ED Discharge for Acute Pain
For patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across...
Transcatheter PDA Closure Increasingly Used for Very Low Birth-Weight Infants
For very low birth-weight (VLBW) infants, transcatheter closure of the patent ductus arteriosus (PDA) is increasingly used, with selected short-term outcomes...
Hospital Admissions for Epilepsy Change With Climatic Factors
Changes in climate are possible trigger factors for seizure-related hospitalizations in patients with epilepsy, according to a study published online June...
PREVENT Equations Show Lower ASCVD Risk Than Pooled Cohort Equations
The 10-year predicted atherosclerotic cardiovascular disease (ASCVD) risk estimated by the Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations...
Shannen Doherty Dies of Breast Cancer at 53
Actress Shannen Doherty, best known for her roles in 1990s television hits such as “Beverly Hills, 90210” and “Charmed," has died at...
Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic Declines
More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows. The latest data, issued...
Five Cases of Bird Flu Reported in Colorado Poultry Workers
Five poultry workers in Colorado have been diagnosed with bird flu, state health officials reported Sunday. "In coordination with the Colorado Department...
Some Diabetes Drugs May Lower Dementia Risk
Some diabetes drugs appear to lower the risk that people with type 2 diabetes will develop dementia or Alzheimer’s disease, a new evidence review says.The...
Supercore Issues Voluntary Worldwide Recall of Hard Steel Capsules & Gold Hard Steel Plus Liquid Due to the Presence of Sildenafil and Acetaminophen
July 12, 2024 -- Supercore Products Group is voluntarily recalling of Hard Steel Capsules & Gold Hard Steel Plus Liquid to the consumer level. FDA...
Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target are Prostate Cancer Patients Resistant to Hormone Therapy
SEOUL, South Korea, July 11, 2024. ADM Korea, a subsidiary of Hyundai Bioscience, announced on the 8th that the first clinical trial target population...
AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease
Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...
Osteoarthritis Raises Risk of Other Chronic Health Conditions
Osteoarthritis could nearly triple a person’s risk of developing a multitude of other chronic illnesses, a new two-decade study finds. People with...
Recently Added
Recently added consumer and prescribing information: Pyzchiva, Ahzantive, Ohtuvayre, Sofdra, Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Kisunla Kisunla (donanemab-azbt) is an amyloid beta-directed antibody indicated for the treatment of early symptomatic Alzheimer’s disease.
- Ahzantive Ahzantive (aflibercept-mrbb) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
- Nypozi Nypozi (filgrastim-txid) is a leukocyte growth factor biosimilar to Neupogen indicated for the treatment of neutropenia, neutropenia...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...